glp 1 select trial SELECT: Glucagon-like peptide-1 receptor agonist in obese patients with cardiovascular disease in the absence of diabetes Long-term kidney outcomes of semaglutide

If confirmed in larger prospective trials, these widely used drugs could offer a new potential approach to breast cancer prevention, especially for women with excess body weight

Tension headaches can be triggered by stress and your sleep can be deprived when you are nauseous or uncomfortable with the recent adjustments

Abraham, M

Compound Tirzepatide is a dual GIP and GLP-1 receptor agonist used to treat type 2 diabetes and support long-term weight management

Starting with a low dose and titrating gradually can help minimise these effects

Fibre-rich foods should feature prominently in your diet, supporting digestive health and providing sustained satiety